Skip to contentH
Haemonetics Corp
H
HAEHaemonetics Corp Q3 2021 · 10-Q
Revenue$240.37M$240.37M−7.2% vs Q3 2020 Net Income$31.88M$31.88M+6.6% vs Q3 2020 EPS Diluted$0.62$0.62+6.9% vs Q3 2020 Gross Profit$120,257,000−6.1% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Haemonetics Corp · CIK 313143 · Engraved from SEC EDGAR
Operating Cash Flowderived$66,291,000−16.4% Free Cash Flowderived$56,918,000−3.4% Margins · derivedGross margin50.0%+0.6 pt vs Q3 2020
Operating margin16.8%+1.0 pt vs Q3 2020
Net margin13.3%+1.7 pt vs Q3 2020
ended Dec 26, 2020 · filed Feb 2, 2021 · 38 d after period end